Grammy Award Winner, Rock and Roll Hall of Fame Inductee, 3-03-2023, 01:02

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Monetary Authority of Singapore Nominates Hakeem App for 2024 Singapore Fintech Excellence Awards 4-11-2024, 18:43